(Q27022866)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

hidradenitis suppurativa

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Jurr Boer

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Jon D Laman

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

1 reference

7 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

published in

Experimental Dermatology

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

735-739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

The prevalence of hidradenitis suppurativa and its potential precursor lesions

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Quality of life impairment in hidradenitis suppurativa: a study of 61 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Psychosocial impact of hidradenitis suppurativa: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Idiopathic granulomatous mastitis: case reports and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

An association of cigarette smoking with recurrent subareolar breast abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Predictors of primary breast abscesses and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

The natural history of hidradenitis suppurativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Statistical analysis strategies for association studies involving rare variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Cigarette smoking as a triggering factor of hidradenitis suppurativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

The relative toxicity of compounds in mainstream cigarette smoke condensate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

The non-neuronal cholinergic system of human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Up-regulation of TNF-alpha secretion by cigarette smoke is mediated by Egr-1 in HaCaT human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Tobacco smoke is related to Th17 generation with clinical implications for psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

The aryl hydrocarbon receptor: a perspective on potential roles in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Identification of ketoconazole as an AhR-Nrf2 activator in cultured human keratinocytes: the basis of its anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

The aryl hydrocarbon receptor in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Role of the xenobiotic receptor in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

21 January 2018

Axillary Hidradenitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Regulatory Mechanisms of Calcineurin Phosphatase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Revisiting the immunomodulators tacrolimus, methotrexate, and mycophenolate mofetil: their mechanisms of action and role in the treatment of IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Thalidomide and lenalidomide: Mechanism-based potential drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Dimethylfumarate for psoriasis: more than a dietary curiosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01552.X

10.1111/J.1600-0625.2012.01552.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22882284%20AND%20SRC:MED&resulttype=core&format=json